What would Mary do?

Trump’s actions call for Lasker-style advocacy

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A diagnosis of cancer brings with it fear and uncertainty. Changes proposed by the Trump administration pose a grave new risk to those who suffer from cancer today or will suffer from cancer in the future. A future which was increasingly optimistic is suddenly far more threatening. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Kevin J. Cullen, MD
Former director, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center; Former chair, board of directors, American Cancer Society; Former member, National Cancer Advisory Board
Table of Contents

YOU MAY BE INTERESTED IN

Kevin J. Cullen, MD
Former director, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center; Former chair, board of directors, American Cancer Society; Former member, National Cancer Advisory Board

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login